MHRA approves COVID-19 vaccine trial in 7 working days

An application for the COVID-19 Oxford Vaccine Trial was made on 18 March and approved on 26 March. The procedures for tailored scientific advice and guidance and a speedy approval process are part of MHRA’s pledge to prioritise clinical trial applications submitted for COVID-19.

SPS commentary:

The BBC reports that the first two patients, of more than 800 recruited, have been treated in the placebo-controlled COVID-19 vaccine trial.


Medicines and Healthcare products Regulatory Agency